PEABODY, Mass., August 18, 2003 -- Bernard M. Gordon, Founder,
Chairman of the Board, and Chief Executive Officer of Analogic
Corporation (ALOG) , announced today that John W. Wood Jr.
will succeed him as Chief Executive Officer (CEO) effective
today, August 18. Gordon will continue to serve as Chairman
of the Board.
Gordon, now 76, recognized as the "father of high-speed analog-to-digital conversion," founded Analogic Corporation in 1969 and is internationally known for the numerous inventions conceived by him and the engineering teams he has led for over five decades. These inventive developments include: digital Doppler radar; the ubiquitous dot matrix computer display; the first high-speed analog-to-digital converter; the first digitization of music and video; the first fetal monitors; the first instant imaging computed tomography (CT) systems; the first quadrature baseband, phased-array ultrasound systems; the first lightweight, mobile CT systems; and the first dual-energy, multislice security CT scanner, among many other innovations. For his pioneering developments, he was awarded the National Medal of Technology in 1986.
Gordon will now focus his efforts toward charting the future technical direction of Analogic, which is recognized worldwide for its inventive engineering of advanced medical and security imaging equipment.
John Wood joined the Company as President in April of this year. Recently, he had served as President of Peek Ltd., a Division of Thermo Electron Corporation, and as a Senior Vice President of the parent company. Prior to that he served for a number of years as President and Chief Executive Officer of Thermedics, a subsidiary of Thermo Electron. Mr. Wood's education includes a Bachelor's degree in Electrical Engineering from Louisiana Tech University and a Master's Degree in Electrical Engineering from the Massachusetts Institute of Technology.
Gordon observed that Wood, age 59, had already been very well received in the Company. "John brings a variety of skills to bear in the Company. He has been involved in the development of innovative medical equipment for decades. Moreover, he played a role in the 1988 investigation of the Pan Am Flight 103 tragedy. Thermedics, under his direction, developed the trace chemical detector that determined the cause of the disaster. John's breadth of engineering background and experience is complemented by a broad range of business and organizational skills. We are confident he will run the Company to take full advantage of its breadth of capabilities, to better exploit the array of opportunities we foresee in both health and security markets."
Wood expressed his gratitude to the Board and to Mr. Gordon for their confidence in him. "It is an honor to be leading Analogic, with its long and enviable history of engineering innovation, particularly in medical imaging applications. The Company has recently made major technological advances in security imaging as well, building on the unique, inventive engineering culture Bernard Gordon has established at Analogic. I look forward to working very closely with the Company's experienced management team and inventive engineering staff to enhance the Company's long-term growth in both health and security imaging technology."
Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems. The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, Cardiovascular Information Management, and Embedded Multicomputing.
Return
to headlines
Announces Cash Dividend for Its Third Quarter
PEABODY, Mass., June 13, 2003--Bernard M. Gordon,
Chairman of the Board and CEO of Analogic Corporation (NASDAQ:ALOG),
a leading designer and manufacturer of high precision health and
security imaging equipment, is pleased to announce that its Board of
Directors, on June 11, 2003, declared an $.08 cash dividend for its
third quarter ended April 30, 2003.
The cash dividend for the third quarter ended April 30, 2003, will
be $.08 for each common share, payable on July 9, 2003, to
shareholders of record on June 25, 2003.
Return
to headlines
Announces Revenues and Earnings for Its Third Quarter
PEABODY, Mass., Jun 12, 2003 -- Analogic Corporation (ALOG) , a leading designer and manufacturer of high precision medical diagnostic and security equipment, announced today revenues and earnings for its third quarter ended April 30, 2003.
Revenues for the third quarter ended April 30, 2003, were $100,334,000, compared with the prior year's third quarter revenues of $72,908,000, an increase of 38%. Net income for the third quarter was $6,438,000, or $.48 per diluted share, compared with $2,747,000, or $.21 per diluted share, for the prior year's third quarter, an increase of 134%.
Revenues for the nine months ended April 30, 2003, were $396,603,000, compared with the prior year's nine months' revenues of $221,320,000, an increase of 79%. Income for the nine-month period was $47,865,000 or $3.59 per diluted share, compared with a net loss of $3,018,000, or ($.23) per diluted share, for the same period a year ago. The net loss for the first nine months of the prior year included a first quarter asset impairment charge of $8,883,000 related to the Company's telecommunications subsidiary, Anatel Communi-ca-tions, and its Test & Measurement Division.
Bernard M. Gordon, Chairman of the Board and CEO, commented, "We are pleased with the improvement shown over the prior third quarter. Much of this was due to continued, albeit much smaller shipments of security imaging equipment. As we indicated last March, security imaging revenues may vary considerably from quarter to quarter. Ship-ments of our EXplosive Assessment Computed Tomography (EXACT(TM)) systems were signifi-cantly less this quarter than in the two immediately preceding quarters. We believe that additional orders for EXACT systems should be forthcoming to meet both domestic and international orders. However, we do not know when such orders will be placed or the quantities that will be required.
"We continue to pursue a number of opportunities for long-term growth by developing other advanced security imaging systems. During the quarter we announced a strategic marketing agreement with Lockheed Martin to market a variety of threat detection prod-ucts to be developed by Analogic. The first product to be marketed under this agreement will be an automated, CT-based portal screening system that can scan carry-on baggage at airports, 'carry-in' baggage at public buildings, and parcels for corporations and delivery services. Initial reactions to the design have been favorable. We are exploring the market, both domestic and international.
"We have completed pre-production of two different ARGUS-type CT scanners for explosive detection at regional airports and are awaiting orders for them. Work continues on the infrared countermeasures system we are developing with Sanders Design to protect civilian aircraft from shoulder-fired missiles. Funding is being sought to develop advanced prototypes for field tests. We are also continuing to invest in a number of other develop-ment projects to meet diverse, evolving security needs in the U.S. and abroad."
President John W. Wood Jr., noted, "Our health businesses demonstrated some solid growth during the quarter. Sales of cardiovascular image and information management equipment by our Camtronics subsidiary and of advanced clinical ultrasound systems by our B-K Medical subsidiary both improved substantially over the prior third quarter. Our new Sound Technology Inc. subsidiary also had a strong quarter manufacturing and mar-ket-ing advanced ultrasound transducers to Original Equipment Manufacturers (OEMs). Sales of Data Acquisition Systems (DASs) for Computed Tomography more than doubled from the prior third quarter, due in large part to our new family of advanced multi-slice DASs."
Gordon added, "While much public attention has been focused on our development of a variety of new security imaging products, we are continuing to focus substantial resources on developing new generations of advanced medical imaging equipment. We have a number of projects underway to provide innovative CT systems for a variety of niche medical markets, as well as digital X-ray systems and subsystems for general radiography applications and mammography.
"Subsequent to the end of the quarter, Analogic acquired a minority interest in PhotoDetection Systems Inc. of Acton, Massachusetts and an exclusive license to use their proprietary Positron Emission Tomography (PET) technology in specific markets. PhotoDetection has developed a unique, proprietary high-performance, low-cost PET detection system. Combining our high-performance low-cost Computed Tomography (CT) systems with their respective proprietary PET technologies considerably enhances our ability to provide superior, innovative PET/CT combination systems to our Original Equipment Manufacturer (OEM) customers."
Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems. The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, Cardiovascular Information Management, and Embedded Multicomputing.
This press release contains the Company's or management's intentions, hopes, beliefs, expectations or predictions. These are considered "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements (statements which are not historical facts) in this presentation are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements, including statements about product development, market and industry trends, strategic initiatives, regulatory approvals, sales, profits, expenses, price trends, research and development expenses and trends, and capital expenditures involve risk and uncertainties and actual events and results may differ significantly from those in any forward-looking statements. Actual results may differ materially from those indicated by such statements as a result of various factors, including those discussed in the Company's periodic reports filed with the SEC.
Return
to headlines
Acquires Minority Interest in PhotoDetection Systems
PEABODY, Mass., May 22, 2003--Analogic Corporation (NASDAQ: ALOG) announced today that it has acquired a minority interest in PhotoDetection Systems Inc. of Acton, Massachusetts. Analogic also obtained an exclusive technology license to use PhotoDetection System's proprietary Positron Emission Tomography (PET) technology within specific markets.
Privately held PhotoDetection Systems, Inc. (PDS), founded at Boston University's Photonics Center in 1998, has developed proprietary detection systems for high-performance Positron Emission Tomography (PET), a rapidly growing medical diagnostic imaging modality. PET scanning is an excellent tool in the diagnosis and management of cancer, specifically for detecting early-stage tumors and determining tissue characteristics before and after treatment.
Bernard M. Gordon, Chairman and CEO of Analogic, observed, "We see significant opportunities for both companies in combining our advanced technologies to serve the newly emerging application of hybrid PET/CT systems, one of the most advanced medical imaging technologies available today. PhotoDetection has developed a unique, proprietary high-performance, low-cost PET detection system. Analogic is a recognized leader in the development of high-performance low-cost Computed Tomography (CT) systems. Combining our respective proprietary technologies, Analogic and PDS have the ability to provide superior, innovative PET/CT systems for our Original Equipment Manufacturer (OEM) customers."
"Our technology dramatically improves the sensitivity of PET images at a significantly lower cost," notes Paul Domigan, President and CEO of PDS. "Analogic's CT imaging technology offers fine anatomical resolution. Combining our technologies means that low-cost PET/CT products will enable more clinicians to detect smaller lesions earlier, thereby improving the survival rates of many patients."
"PET/CT is an emerging medical imaging field that offers a major opportunity for the Company," commented Analogic President, John W. Wood Jr. "The key to PET/CT is its ability to combine the strengths of both PET and CT to offer a higher level of diagnostic power, improving cancer imaging by identifying diseases not perceptible in the separate PET or CT scan. Not only does PET/CT provide superior images; it is able to do so very quickly, significantly reducing the time and therefore the cost for scanning the patient, a benefit for patient and clinic alike. PDS' and Analogic's proprietary technology can also reduce the cost of purchasing and operating PET/CT systems, making the benefits of these advanced hybrid systems more readily available to clinicians and patients."
Terms of the investment were not disclosed.
Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, Cardiovascular Information Management, and Embedded Multicomputing.
Return
to headlines
Announces Third Quarter Investor Conference Call
PEABODY, Mass., May 19, 2003--Analogic
Corporation (NASDAQ:ALOG) today announced that it will conduct an
investor conference call on Thursday, June 12, at 4:00 p.m. ET to
discuss third-quarter results. Those results will be released before
the market opens on June 12. The conference call will include Bernard
M. Gordon, Chairman of the Board & CEO; John W. Wood Jr., President;
John J. Millerick, Senior Vice President, CFO & Treasurer; and Julian
Soshnick, Vice President & General Counsel. Brief presentations by
management will be followed by a question-and-answer session.
The call will be available via a webcast. To listen to the
webcast, visit www.analogic.com approximately five to ten minutes
before the conference is scheduled to begin.
The replay of the conference call webcast will be archived at
www.analogic.com approximately three hours after the call is completed
and will be available through Wednesday, June 25, 2003.
A telephone digital replay will be available approximately two
hours after the call is completed until 8:00 p.m. ET on Friday, June
13. To access the digital replay, dial 1-800-642-1687. The conference
ID number is 660974.
Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold to Original
Equipment Manufacturers (OEMs). The Company is recognized worldwide
for advancing the state of the art in Computed Tomography (CT),
Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), Patient Monitoring, Cardiovascular Information Management, and
Embedded Multicomputing.
Return
to headlines
Bernard Gordon, Executive Chairman and Chairman of the Board, to Receive the International Engineering Consortium's Fellow Award
CHICAGO, May 8, 2003--Bernard Gordon, Executive
Chairman and Chairman of the Board, Analogic Corporation
(NASDAQ:ALOG), has been selected to receive the International
Engineering Consortium's Fellow Award. Mr. Gordon's distinguished
career presents a record of leadership and innovation spanning a
diverse range of technologies, including contributions to
analog-to-digital conversion, tomography, and medical and other
high-precision instrumentation.
The IEC Board of Directors established the Fellow Award in 1994 to
recognize individuals who have provided the electronics and
information industries with a superior level of sustained, significant
service. Areas of service considered include education, technology,
and industry leadership contributions. Among the 88 previous
recipients of the Fellow Award are Jack Kilby (Texas Instruments),
Robert Metcalf (Technology Internet Data Group), Gordon Moore (Intel
Corporation), and David Packard (Hewlett-Packard).
"Bernard Gordon's lifetime contribution to the development of the
industry is remarkable," says Robert Janowiak, Executive Director of
the International Engineering Consortium. "He has provided outstanding
leadership in applying high technology to solve real-world problems.
Throughout his career, Bernard has effectively identified applications
for technology that are not only commercially successful but also
socially beneficial."
Gordon is the founder, chairman, and chief executive officer of
Massachusetts-based Analogic Corporation. He holds more than 200
patents worldwide. A lifelong inventor, his creations include the
fetal monitor, the high-speed analog-to-digital converter, the instant
imaging computer-aided tomography scanner, Doppler radar, and an
advanced bomb-detection device. Mr. Gordon established Analogic as a
worldwide leader in areas such as ultrasonography and digital imaging,
supplying the digital electronic processing subsystems for the leading
laser imagers in the industry.
The IEC Fellow award will be presented to Mr. Gordon at the IEC's
DesignCon East conference June 24, 2003, in Marlborough,
Massachusetts.
About the IEC
The International Engineering Consortium (IEC) is a nonprofit
organization dedicated to catalyzing technology and business progress
worldwide in a range of high-technology industries and university
communities. Since 1944, the IEC has provided high-quality educational
opportunities for industry professionals, academics, and students. In
conjunction with industry-leading companies, the IEC has developed an
extensive, free, on-line educational program. The IEC conducts
industry-university programs that have substantial impact on
curricula. It also conducts research and develops publications,
conferences, and technological exhibits that address major
opportunities and challenges of the information age. More than 70
leading high-technology universities are IEC affiliates, and the IEC
handles the affairs of the Electrical and Computer Engineering
Department Heads Association.
Return
to headlines
Announces Cash Dividend For Its Second Quarter
PEABODY, Mass., March 12, 2003--Bernard M.
Gordon, Chairman of the Board, President and CEO of Analogic
Corporation (NASDAQ:ALOG), a leading designer and manufacturer of high
precision health and security imaging equipment, is pleased to
announce that its Board of Directors, on March 11, 2003, declared an
$.08 cash dividend for its second quarter ended January 31, 2003.
The cash dividend for the second quarter ended January 31, 2003,
will be $.08 for each common share, payable on April 8, 2003, to
shareholders of record on March 25, 2003.
Return
to headlines
Announces Record Revenues and Earnings for Its Second Quarter
PEABODY, Mass., March 12, 2003--Analogic
Corporation (NASDAQ-ALOG), a leading designer and manufacturer of high
precision health and security imaging equipment, announced today
revenues and earnings for its second quarter ended January 31, 2003.
Revenues for the second quarter ended January 31, 2003, were a
record $160,567,000, compared with the prior year's second quarter
revenues of $72,610,000, an increase of 121%. Net income for the
second quarter was a record $21,256,000, or $1.59 per diluted share.
This compares with a net income of $605,000, or $0.05 per diluted
share, for the prior year's second quarter.
Revenues for the six months ended January 31, 2003, were a record
$296,269,000, compared with the prior year's six months' revenues of
$148,412,000, an increase of 100%. Net income for the six-month period
was $41,427,000 or $3.11 per diluted share, compared with net loss of
$5,765,000, or ($.44) per diluted share, for the same period a year
ago. The net loss for the first six months of the previous year
included a first quarter asset impairment charge of $8,883,000 related
to the Company's telecommunications subsidiary, Anatel Communications,
and certain assets of the Test & Measurement Division. Excluding the
asset impairment charges, net income for the first half of the prior
year would have been approximately $1,341,000 or $.10 per diluted
share.
Bernard Gordon, Chairman of the Board and CEO, commented, "We are
very pleased with the results of the quarter, which went as
anticipated. The record revenue and income were due primarily to an
increase in our security imaging business. During the quarter we
shipped a record number of our advanced EXplosive Assessment Computed
Tomography (EXACT(TM)) systems to L-3 Communications (NYSE:LLL) for
use in government-certified Explosive Detection Systems (EDS) that
screen checked luggage for aircraft. Altogether, during Calendar 2002
we shipped a total of 425 EXACT systems to our customer, on or ahead
of schedule, to help airports comply with the mandates of the Aviation
and Transportation Security Act of 2001.
"In December we received a purchase order from L-3 Communications
to deliver an additional 75 EXACT systems during the first four months
of calendar 2003 for foreign and other anticipated orders. We believe
that additional orders for EXACT systems should be forthcoming. At
this time we do not know when such orders will be placed or the
quantities that will be required. We therefore expect that security
imaging revenues may vary significantly from quarter to quarter.
"What is clear is that there is a continuing airport demand for
certified EDS systems that can be deployed inline. Placing EDS systems
inline, away from passenger check-in areas, is the fastest, most
efficient means of scanning checked luggage, and will enable airports
to considerably reduce costs and eliminate passenger lines at
stand-alone EDS systems deployed in the lobbies of many airports."
Gordon noted, "We are confident that there are other opportunities
for long-term growth in developing security imaging systems for a
variety of applications. For example, we are in the initial stages of
testing prototypes of an automated, CT-based portal screening system
that can scan carry-on baggage at airports, 'carry-in' baggage at
public buildings, and parcels for corporations and delivery services.
We are also continuing to increase our investment in a number of other
development projects to meet diverse, evolving security needs in the
U.S. and abroad.
"Our health businesses remained solid during the quarter, with
significant growth in shipments of our CT Data Acquisition Systems
(DAS's), including a new generation of 16-slice CT DAS's, of clinical
ultrasound equipment developed by our B-K Medical subsidiary, and of
ultrasound transducers by our new Sound Technology Inc., subsidiary.
We are continuing to focus substantial resources," Gordon added, "in
developing new generations of medical imaging equipment, including
innovative CT systems for niche markets, advanced digital X-ray
systems and subsystems for general radiography and mammography, and an
extended family of multislice CT Data Acquisition Systems for both
medical and security applications.
"Our recently recognized technological achievements in both health
and security applications, and our expanded advanced system
manufacturing facilities, have attracted considerable attention in the
marketplace and are generating a number of major new business
opportunities. We are very fortunate to have the contract to supply
EDS systems for use by the Transportation Security Administration and
the revenue, profits and cash flow it is generating for the Company.
We are presently using these funds to identify and acquire, either
through internal development efforts or acquisition, new products and
technologies for the Company. We believe that our achievements over
the first half of this fiscal year and our considerable investment in
new product development in both health and security applications will
help position the Company for continuing, long-term growth."
Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold primarily to
Original Equipment Manufacturers (OEMs). The Company is recognized
worldwide for advancing the state of the art in Computed Tomography
(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), Patient Monitoring, Cardiovascular Information Management, and
Embedded Multiprocessing.
This press release contains the Company's or management's
intentions, hopes, beliefs, expectations or predictions. These are
considered "forward-looking statements" within the meaning of the
Private Securities Litigation Act of 1995. Forward-looking statements
(statements which are not historical facts) in this presentation are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Investors are cautioned that all
forward-looking statements, including statements about product
development, market and industry trends, strategic initiatives,
regulatory approvals, sales, profits, expenses, price trends, research
and development expenses and trends, and capital expenditures involve
risk and uncertainties and actual events and results may differ
significantly from those in any forward-looking statements. Actual
results may differ materially from those indicated by such statements
as a result of various factors, including those discussed in the
company's periodic reports filed with the SEC.
Return
to headlines
Announces John W. Wood Jr. to be New President
PEABODY, Mass., March 11, 2003--Bernard M.
Gordon, founder, Chairman of the Board and Chief Executive Officer of
Analogic Corporation (NASDAQ:ALOG), announced today that the Board of
Directors has selected John W. Wood Jr. to be President of the
Company. Mr. Wood will join Analogic in April.
Most recently Mr. Wood has served as President of Peek Ltd., a
Division of Thermo Electron Corporation, and as a Senior Vice
President of the parent company. Prior to that he served for a number
of years as President and Chief Executive Officer of Thermedics, a
majority owned public subsidiary of Thermo Electron. Mr. Wood's
education includes a Bachelor's degree in Electrical Engineering from
Louisiana Tech University and a Master's Degree in Electrical
Engineering from the Massachusetts Institute of Technology.
Mr. Gordon commented, "We are pleased to have a recognized
industry leader with John's vision and experience join the Analogic
team. His considerable engineering knowledge, and his proven
leadership and management skills are important assets for the future
of the Company. Our Senior Management Group and I will be working
closely with John during the next several months to assist him in
making a smooth transition to leader of the Company."
"I am very proud to become part of Analogic," noted Wood. "The
Company has a long and enviable history of engineering innovation,
particularly in medical imaging applications. Recently the Company's
substantial engineering and scientific staff has achieved major
advances in security imaging as well, building on the unique,
inventive engineering culture Bernard Gordon has established at
Analogic. I look forward to working closely with the Company's
experienced management team and to contributing to the Company's
long-term growth in both health and security imaging technology."
Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold primarily to
Original Equipment Manufacturers (OEMs). The Company is recognized
worldwide for advancing the state of the art in Computed Tomography
(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), Patient Monitoring, Cardiovascular Information Management, and
Embedded Multiprocessing.
Return
to headlines
Announces Second Quarter Investor Conference Call
PEABODY, Mass., February 25, 2003--Analogic
Corporation (NASDAQ:ALOG) today announced that it will conduct an
investor conference call on Wednesday, March 12, at 9:30 a.m. ET to
discuss second-quarter results. Those results will be released before
the market opens on March 12. The conference call will include Bernard
M. Gordon, Chairman of the Board & CEO; John J. Millerick, Senior Vice
President, CFO & Treasurer; and Julian Soshnick, Vice President &
General Counsel. Brief presentations by management will be followed by
a question-and-answer session.
The call will be available via a webcast. To listen to the
webcast, visit www.analogic.com approximately five to ten minutes
before the conference is scheduled to begin.
The replay of the conference call webcast will be archived at
www.analogic.com approximately three hours after the call is completed
and will be available through Tuesday, March 25, 2003.
A telephone digital replay will be available approximately two
hours after the call is completed until 8:00 p.m. ET on Thursday,
March 13. To access the digital replay, dial 1-800-642-1687. The
conference ID number is 8410062.
Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold to Original
Equipment Manufacturers (OEMs). The Company is recognized worldwide
for advancing the state of the art in Computed Tomography (CT),
Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), Patient Monitoring, Cardiovascular Information Management, and
Embedded Multiprocessing.
Return
to headlines
To Expand Facilities at Corporate Headquarters in Peabody, Mass.
PEABODY, Mass., February 3, 2003--Bernard M. Gordon,
Chairman of the Board and CEO of Analogic Corporation (NASDAQ:ALOG),
announced today that the Company is planning to construct a 100,000
square foot addition to its headquarters building in Peabody,
Massachusetts. The headquarters currently encompasses over 400,000
square feet of engineering, manufacturing and administrative space.
Gordon said, "We are aggressively pursuing new opportunities in
health and security applications that are expected to lead to
significant long-term growth for Analogic. This two-story addition
will enable the Company to further consolidate its existing
Massachusetts operations and to expand production capacity for its
medical and security imaging system businesses. A significant
investment in our future, this expansion reaffirms our strong
commitment to meeting the growing needs of our customers."
Ground breaking is expected to occur in March 2003, with
completion expected the following December. Architects on the project
are Stubbins Associates, Cambridge, Massachusetts.
This will be the second major expansion in eastern Massachusetts
by Analogic within the past year. In April the Company leased a
200,000 square foot building in Haverhill, Massachusetts, and
transformed it into the world's most advanced manufacturing facility
for security Computed Tomography (CT) scanners, used in explosive
detection systems that screen checked luggage for aircraft.
Two Analogic subsidiaries, Camtronics Medical Systems in Hartland,
Wisconsin, and B-K Medical in Herlev, Denmark, recently doubled the
size of their respective headquarters, including engineering and
manufacturing facilities.
Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold to Original
Equipment Manufacturers (OEMs). The Company is recognized worldwide
for advancing the state of the art in Computed Tomography (CT),
Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), Patient Monitoring, Cardiovascular Information Management, and
Embedded Multiprocessing.
This press release contains the Company's or management's
intentions, hopes, beliefs, expectations or predictions. These are
considered "forward-looking statements" within the meaning of the
Private Securities Litigation Act of 1995. Forward-looking statements
(statements which are not historical facts) in this presentation are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Investors are cautioned that all
forward-looking statements, including statements about product
development, market and industry trends, strategic initiatives,
regulatory approvals, sales, profits, expenses, price trends, research
and development expenses and trends, and capital expenditures involve
risk and uncertainties and actual events and results may differ
significantly from those in any forward-looking statements. Actual
results may differ materially from those indicated by such statements
as a result of various factors, including those discussed in the
Company's periodic reports filed with the SEC.
Return
to headlines